Attenuation of sepsis-induced rat liver injury by epigallocatechin gallate via suppression of oxidative stress-related inflammation
Purpose: To evaluate the effect of epigallocatechin gallate (EGCG) on sepsis-induced liver injury in a rat model of sepsis established by cercal ligation and puncture (CLP).
Methods: Male Wistar rats were randomly divided into 6 groups (n = 12): normal control, sepsis, dexamethasone (5 mg/kg), low-dose EGCG (12.5 mg/kg), medium-dose EGCG (25 mg/kg), and highdose EGCG (50 mg/kg) groups. Dexamethasone and EGCG were given once daily. Survival rates following CLP were recorded. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured to evaluate liver function. Tumor necrosis factor-α (TNF-α) and interleukin (IL)-10 were determined by ELISA. Superoxide dismutase (SOD) and levels of glutathione (GSH) and malondialdehyde (MDA) were assayed to evaluate oxidative stress. Protein and mRNA expression levels of heme oxygenase-1 (HO-1) and nuclear factor erythroid 2-related factor (Nrf2) were measured by Western blotting and quantitative real-time polymerase chain reaction (qRT-PCR), respectively.
Results: Survival rates were significantly (p < 0.05) increased by EGCG (83.3 %) when compared to the untreated sepsis group (33.3 %) or dexamethasone-treated sepsis group (41.7 %). The increase in survival rates was associated with significant decreases in AST, ALT, MDA, and TNF-α, and significant elevations in SOD, GSH, and IL-10. QRT-PCR and Western blotting data indicate that there was increase in hepatic expression of Nrf-2 and HO-1 of EGCG-treated sepsis rats, relative to the untreated sepsis group.
Conclusion: These results suggest that EGCG treatment reduces sepsis-induced liver injury and improves the survival rate of rats with polymicrobial sepsis by reducing oxidative stress via regulation of Nrf2/HO-1 signaling. These findings highlight the promising potential of EGCG for the treatment of sepsis.
Keywords: Epigallocatechin gallate, Cecal ligation and puncture (CLP), Sepsis, Liver injury, Oxidative stress, Inflammation
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.